Publications by authors named "J Urbain"
Article Synopsis
- - The Lancet Oncology Commission focuses on improving global access to radiotherapy and theranostics, addressing significant disparities between high-income countries and low-income and middle-income countries (LMICs) concerning available treatment resources and trained healthcare professionals.
- - The implementation of hypofractionation techniques in radiotherapy could increase treatment access for millions of patients with prostate and breast cancer, highlighting the need for new technologies in LMICs with existing resources.
- - A global survey revealed variability in the use of radiopharmaceutical therapy, with issues related to supply chains and workforce training impacting access; initiatives like the International Atomic Energy Agency's Rays of Hope program and investment from development banks are encouraged to improve the situation.
Theranostics has become a major area of innovation and progress in cancer care over the last decade. In view of the introduction of approved therapeutics in neuroendocrine tumours and prostate cancer in the last 10 years, the ability to provide access to these treatments has emerged as a key factor in ensuring global benefits from this cancer therapy approach. In this Series paper we explore the issues that affect access to and availability of theranostic radiopharmaceuticals, including supply and regulatory issues that might affect the availability of theranostic treatments for patients with cancer.
View Article and Find Full Text PDFArticle Synopsis
- * The rapid advancement in diagnostic and therapeutic radiopharmaceuticals, particularly in oncology, presents exciting opportunities but also challenges, like inadequate infrastructure for production and distribution.
- * A critical challenge is ensuring equitable access to these innovations, which requires developing a trained workforce across varying income levels in different countries.
Article Synopsis
- This paper is the first in a series about theranostics, which is a way to use special medicines to help treat cancer.
- It talks about new and cool discoveries in making these medicines and using smart technology to improve them.
- The authors also mention some problems that need to be solved to make these cancer treatments even better in the future.
Article Synopsis
- The synchronous development of radiotherapy (RT) and theranostics is essential for improving survival and quality of life for cancer patients worldwide.
- An international collective, organized by the IAEA, analyzed and compared the challenges and advances in RT and theranostics infrastructure in six countries: Belgium, Brazil, Costa Rica, Jordan, Mongolia, and South Africa.
- Despite progress, significant disparities in the availability of medical professionals persist, and enhancing collaboration, implementing audits, and adopting innovative technologies are key to accelerating advancements in cancer treatment globally.